Last $75.24 USD
Change Today -1.88 / -2.44%
Volume 199.4K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for furiex pharmaceuticals (FURX)

Furiex Pharmaceuticals, Inc. may have more financial risk than other companies in the Life Sciences Tools and Services industry as it is one of the most highly leveraged with a Debt to Total Capital ratio of 75.56%. This ratio actually increased over the last year. However, an examination of near-term assets and liabilities shows that there are enough liquid assets to satisfy current obligations. Accounts Receivable are among the industry's worst with 51.21 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents82.033.625.729.2
Short-Term Investments--10.0----
TOTAL CASH AND SHORT TERM INVESTMENTS82.043.625.729.2
Accounts Receivable0.32.011.78.2
TOTAL RECEIVABLES0.32.011.78.2
Prepaid Expenses0.20.20.30.4
Other Current Assets0.7------
TOTAL CURRENT ASSETS83.345.837.837.7
Gross Property Plant and Equipment0.20.30.30.4
Accumulated Depreciation-0.1-0.1-0.2-0.3
NET PROPERTY PLANT AND EQUIPMENT0.20.20.10.1
Goodwill49.149.149.149.1
Long-Term Investments----7.5--
Deferred Charges, Long Term----0.21.5
TOTAL ASSETS132.695.194.888.4
    
LIABILITIES & EQUITY    
Accounts Payable0.10.16.67.1
Accrued Expenses13.810.410.25.3
Current Portion of Long-Term Debt/Capital Lease--1.45.410.6
TOTAL CURRENT LIABILITIES13.911.922.223.0
Long-Term Debt--8.634.646.4
Deferred Tax Liability Non-Current0.20.20.20.2
Other Non-Current Liabilities--0.00.10.4
TOTAL LIABILITIES14.120.857.270.0
Common Stock0.00.00.00.0
Additional Paid in Capital153.6158.4164.6175.1
Retained Earnings-35.1-84.1-127.0-156.7
TOTAL COMMON EQUITY118.574.337.618.4
TOTAL EQUITY118.574.337.618.4
TOTAL LIABILITIES AND EQUITY132.695.194.888.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FURX:US $75.24 USD -1.88

FURX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 3,782 GBp +23.00
Eli Lilly & Co $60.43 USD +0.47
Merck & Co Inc $56.47 USD +0.21
View Industry Companies
 

Industry Analysis

FURX

Industry Average

Valuation FURX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.9x
Price/Book 42.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FURIEX PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.